Brief: Forward Pharma To Transfer U.S. Public Listing To Nasdaq Capital Market Stock Exchange
26/06/2019 21:34
June 26 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA A/S ANNOUNCES INTENTION TO TRANSFER ITS
U.S.
PUBLIC LISTING TO THE NASDAQ CAPITAL MARKET STOCK EXCHANGE
* FORWARD PHARMA A/S - ANNOUNCED INTENTION TO TRANSFER
PUBLIC
LISTING OF ADSS FROM NASDAQ GLOBAL SELECT MARKET TO NASDAQ
CAPITAL MARKET
Source text for Eikon: ID:nGNX95HDcZ
Further company coverage: FWP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA